,
Inaguma, Daijo https://orcid.org/0000-0002-3977-5933
Ito, Eri
Takahashi, Kazuo
Hayashi, Hiroki
Koide, Shigehisa
Hasegawa, Midori
Yuzawa, Yukio
Funding for this research was provided by:
Aichi Kidney Foundation
Article History
Received: 15 January 2018
Accepted: 20 May 2018
First Online: 7 June 2018
Compliance with ethical standards
:
: YY has received research support grants from Otsuka Pharmaceutical Co., Ltd, Kyowa Hakko Kirin Co., Ltd, and Chugai Pharmaceutical Co., Ltd. DI has received lecture fees from Kyowa Hakko Kirin Co., Ltd. and Ono Pharmaceutical Co., Ltd. Other authors have nothing to declare.
: This study was conducted by following Ethical guidelines for Clinical Research by the Japanese Ministry of Health, Labor, and Welfare (created July 30, 2003; full revision December 28, 2004; full revision July 31, 2008) and the Helsinki Declaration (revised 2013) and was approved by the clinical research ethics committees at each AICOPP group facility (the approval number: 20110823-3).
: The subjects received oral and written explanations of the purpose of the study and provided their consent in writing. Trial registration is UMIN 7096. Registered 18 January 2012.